» Articles » PMID: 37509375

Can Bee Venom Be Used As Anticancer Agent in Modern Medicine?

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jul 29
PMID 37509375
Authors
Affiliations
Soon will be listed here.
Abstract

Honey bee venom in its composition contains many biologically active peptides and enzymes that are effective in the fight against diseases of various etiologies. The history of the use of bee venom for medicinal purposes dates back thousands of years. There are many reports in the literature on the pharmacological properties of bee venom and/or its main components, e.g., anti-arthritic, anti-inflammatory, anti-microbial or neuroprotective properties. In addition, both crude venom and melittin exhibit cytotoxic activity against a wide range of tumor cells, with significant anti-metastatic activity in pre-clinical studies. Due to the constantly increasing incidence of cancer, the development of new therapeutic strategies in oncology is a particular challenge for modern medicine. A review paper discusses the various properties of bee venom with an emphasis on its anticancer properties. For this purpose, the PubMed database was searched, and publications related to "bee", "venom", "cancer" from the last 10 years were selected.

Citing Articles

Cytotoxic effects of bee venom-loaded ZIF-8 nanoparticles on thyroid cancer cells: a promising strategy for targeted therapy.

Ilhan H, Kabakci D, Secme M Med Oncol. 2024; 42(1):32.

PMID: 39699709 DOI: 10.1007/s12032-024-02584-2.


In vitro cytotoxicity assessment of biosynthesized Apis mellifera bee venom nanoparticles (BVNPs) against MCF-7 breast cancer cell lines.

Jadhav V, Bhagare A, Palake A, Kodam K, Dhaygude A, Kardel A Discov Nano. 2024; 19(1):170.

PMID: 39402248 PMC: 11473470. DOI: 10.1186/s11671-024-04123-4.


Therapeutic Potential and Mechanisms of Bee Venom Therapy: A Comprehensive Review of Apitoxin Applications and Safety Enhancement Strategies.

Stela M, Cichon N, Splawska A, Szyposzynska M, Bijak M Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338374 PMC: 11434713. DOI: 10.3390/ph17091211.


Antitumor Effects and the Potential Mechanism of 10-HDA against SU-DHL-2 Cells.

Tian Y, Liu X, Wang J, Zhang C, Yang W Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204193 PMC: 11357620. DOI: 10.3390/ph17081088.


Effect of Bee Venom on Glioblastoma Cancer: In Vitro and In Vivo Studies.

Chahla C, Rima M, Mouawad C, Roufayel R, Kovacic H, El Obeid D Molecules. 2024; 29(16).

PMID: 39203027 PMC: 11357583. DOI: 10.3390/molecules29163950.


References
1.
Yang E, Kim S, Yang S, Lee S, Choi S . Melittin restores proteasome function in an animal model of ALS. J Neuroinflammation. 2011; 8:69. PMC: 3142224. DOI: 10.1186/1742-2094-8-69. View

2.
Cherniack E, Govorushko S . To bee or not to bee: The potential efficacy and safety of bee venom acupuncture in humans. Toxicon. 2018; 154:74-78. DOI: 10.1016/j.toxicon.2018.09.013. View

3.
Kim W, An H, Kim J, Gwon M, Gu H, Jeon M . Anti-Inflammatory Effect of Melittin on Porphyromonas Gingivalis LPS-Stimulated Human Keratinocytes. Molecules. 2018; 23(2). PMC: 6017529. DOI: 10.3390/molecules23020332. View

4.
Zheng J, Lee H, Ham Y, Song H, Song M, Hong J . Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget. 2015; 6(42):44437-51. PMC: 4792567. DOI: 10.18632/oncotarget.6295. View

5.
Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M . Peptide inhibitors against herpes simplex virus infections. J Pept Sci. 2013; 19(3):148-58. DOI: 10.1002/psc.2489. View